Balance Sheet Data
Salarius Pharmaceuticals, Inc. (SLRX)
$0.6901
-0.02 (-2.80%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 9.83 | 3.74 | 11.12 | 29.21 | 12.11 | 50.15 | 100.25 | 200.39 | 400.56 | 800.71 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.01 | 0.04 | 0.06 | 0.02 | 0.04 | 0.09 | 0.18 | 0.35 | 0.70 | 1.40 |
| Account Receivables (%) | ||||||||||
| Inventories | 0.19 | 0.77 | 1.17 | 0.41 | 0.82 | 1.64 | 3.28 | 6.56 | 13.11 | 26.20 |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.11 | 1.79 | 1.85 | 1.54 | 2.86 | 5.60 | 11.19 | 22.38 | 44.73 | 89.41 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | - | - | -0 | -0 | -0 | -0 | -0.01 | -0.01 | -0.03 | -0.06 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.